Por favor, use este identificador para citar o enlazar este ítem: http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/993
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Walls, A
Park, Y
Tortorici, M
Wall, A
McGuire, A
Veesler, D
Acceso Abierto
Atribución-NoComercial-SinDerivadas
The emergence of SARS-CoV-2 has resulted in >90,000 infections and >3,000 deaths. Coronavirus spike (S) glycoproteins promote entry into cells and are the main target of antibodies. We show that SARS-CoV-2S uses ACE2 to enter cells and that the receptor-binding domains of SARS-CoV-2S and SARS-CoV S bind with similar affinities to human ACE2, correlating with the efficient spread of SARS-CoV-2 among humans. We found that the SARS-CoV-2S glycoprotein harbors a furin cleavage site at the boundary between the S1/S2 subunits, which is processed during biogenesis and sets this virus apart from SARS-CoV and SARS-related CoVs. Wedetermined cryo-EM structures of the SARS-CoV-2S ectodomain trimer, providing a blueprint for the design of vaccines and inhibitors of viral entry.Finally, we demonstrate that SARS-CoV S murine polyclonal antibodies potently inhibited SARS-CoV-2 S mediated entry into cells, indicating that cross-neutralizing antibodies targeting conserved S epitopes can be elicited upon vaccination.
Cell
2020
Preimpreso
https://coronavirus.1science.com/item/88289923c4ac89957a74f138ebaf19dbcd04d4e9
Inglés
VIRUS RESPIRATORIOS
Aparece en las colecciones: Artículos científicos

Cargar archivos:


Fichero Tamaño Formato  
104341.pdf3.51 MBAdobe PDFVisualizar/Abrir